Bias and Pancreatic Cancer Reporting

J Natl Cancer Inst. 2022 May 9;114(5):641-642. doi: 10.1093/jnci/djac020.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenocarcinoma*
  • Antineoplastic Combined Chemotherapy Protocols
  • Bias
  • Fluorouracil
  • Humans
  • Irinotecan
  • Leucovorin
  • Oxaliplatin
  • Pancreatic Neoplasms*
  • Retrospective Studies

Substances

  • folfirinox
  • Oxaliplatin
  • Irinotecan
  • Leucovorin
  • Fluorouracil